ALSUntangled #60: light therapy

ALSUntangled No. 22: Propofol.

ISSN 2167-8421 print/ISSN 2167-9223 online © 2013 Informa Healthcare DOI: 10.3109/21678421.2013.826469 neuroinfl ammation (18,19) occur in ALS, although attempts to manipulate these events have not yet shown clear benefi ts in human ALS trials. Propofol has a short half-life; once infusion is stopped, its clinical effects last only minutes (3). For this reason, it is diffi cult to understand ho...

ALSUntangled No. 34: GM604

ALSUntangled update 4: investigating the XCell-Center.

ALSUntangled No. 11: Nu Tech Mediworld.

Now 26 months old, ALSUntangled (www.alsuntangled. org) investigates alternative and off-label treatment options in ALS using social networking tools. Our twitter and NING memberships continue to grow. To date we have published 10 investigations on 11 different alternative and off-label treatment options, collaborating with Quackwatch (www. quackwatch.org), Patients Like Me (www.patients likeme...

Light Therapy

The susceptibility of the circadian system to selective phase shifting by timed light exposure has broad implications for the treatment of sleep-phase and depressive disorders. Light therapies have been devised that can normalize the patterns of delayed sleep phase syndrome (through circadian phase advances) and advanced sleep phase syndrome (through circadian phase delays). Doctors and patient...